Posted on March 15, 2016 by Mary Camp Another HIMSS conference makes it three in a row for me. I feel like a veteran and enjoyed sharing my inside tips for rookies: arrive early for your sessions to get a seat, choose comfort over style in footwear, pack snacks and water, be […]
Looking back on MEMOTEXT’s accomplishments this fall
Posted on December 2, 2015 by Noah Nemoy
This autumn has been an exciting time for MEMOTEXT. In September our Founder and President Amos Adler had the opportunity to be a main stage speaker at Stanford Medicine X 2015. Presenting the abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” Amos rocked the crowd explaining the MEMOTEXT methodology. He had a fantastic time at the event and the “Cat pics + health data = behavior change” line got a substantial amount of press coverage.
Posted on November 05, 2015 by Noah Nemoy
Medication Compliance is one of the biggest costs to worldwide healthcare systems. 50% of all patients do not take their medication as prescribed and this costs the U.S. healthcare system alone $290 billion per year. That’s a pretty massive figure that can be interpreted in several ways.
We can start by breaking down that $290 billion to show exactly how low compliance rates create such a huge cost:
Posted on October 02, 2015 by Amos Adler
Keywords: #MedXHangover #EmpathyX #MedXorcism, #ActionX
So I’m currently suffering from what’s known as #MedXHangover. Its real, I assure you. Fortunately I don’t have #SyndromeX, a condition associated with attending uncomfortable doctor-patient simulations to simulate uncomfortable doctor-patient interactions.
How MEMOTEXT helps you achieve it
Posted on October 13, 2015 by Noah Nemoy
If you’re an American health care provider or are involved in digital health, odds are you’ve been hearing a lot about Meaningful Use (MU) Stage 3 in recent years. But what is it exactly? Why does it matter? And while we’re at it, what is MU Stages 1 and 2?
Director of Scientific Development Bill Simpson unveils our new BAM adherence metric
Posted on June 26, 2015 by Bill Simpson
2 weeks ago MEMOTEXT had the privilege of presenting our new Balanced Adherence Metric (BAM) at the inaugural Science of Medication Adherence Conference (SMA2015), hosted by the University of Pittsburgh Centre for Pharmaceutical Policy and Prescribing.
Posted on March 05, 2015 by Amos Adler
Some of our MEMOTEXT programs personalize interventions based on what’s known as stages of change. Stage of change, or the transtheoretical model, is used to asses and prescribe appropriate information, motivation and guidance to move people towards behavior change. In plain English, are people ready to adopt healthier behaviors?
Posted on March 02, 2015 by Amos Adler
WARNING: This blog post may offend some innovation seekers while inspiring others
I recently had an interaction with an organization supports innovation in knowledge-based industries. Several discussions with a representative of the organization revealed to me something that was a bit more common than I wanted to acknowledge: There are a lot of organizations that support the idea of innovation but have no real framework for it.
Posted on February 6, 2015 by Noah Nemoy
The past year has been one of tremendous growth and new opportunities for both MEMOTEXT – one of the pioneering mHealth companies – and mHealth as a whole. The two trends that power the mHealth revolution; increased usage of mobile technology and the move towards decentralized and personalized health care, have continued unabated. While mHealth is an industry still largely in its infancy, the use of this technology will only increase as the gap between the 10% of smartphone owners using health apps and 72% of patients using mobile apps, continues to close.
Posted on February 2, 2015 by Bill Simpson
I am not a medical historian, but I would bet that if you asked one, they would identify the synthesis of Aspirin in 1897 as one of most significant moments in modern medicine. With its pain-relieving, anti-inflammatory and anti-platelet (blood thinning) properties packaged within a single tablet, Aspirin provided a safe, effective and easy treatment for a wide range of illnesses. Even today, it is listed on the World Health Organization’s List of Essential Medicines and is taken daily by millions of people for the prevention of heart attacks and strokes. Its synthesis (and the pharmaceutical revolution it helped to user in) has no doubt helped to increase our lifespan and bring about a higher quality of life.